The Sackler family, owners of Purdue Pharma, reached a $7.4 billion settlement to resolve mass opioid litigation. The Department of Justice filed a civil lawsuit against Walgreens over allegations it ...

AbbVie is currently addressing serious health ... 30% from Western Europe, Canada, Japan and Australia and 40% from the fastest-growing economies, including India, China, Russia and Brazil.

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and ...

The new first-line MCL indication gives Calquence a slice of the market of its own and could spur further growth of the drug, ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several ... has gained exclusive commercial rights in the U.S. and Canada to Kloxxado, an emergency nasal spray for opioid ...

Merck, known as MSD outside of the United States and Canada, will gain CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical in a deal potentially worth up to $1.3 billion. This ...

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...

There are several Canadian companies that offer funds that invest in U.S. stocks with a covered call strategy. One is ...